- Ann Arbor, MI
- CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.
- Jim Sherblom, Harvey David Humes
- Medical Device, Health Care, Life Science
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
Funding Rounds (4) - $50.2MUpdate
Board Members and Advisors (3)Update
|Mar 19, 2014||SEC - SEC FORM D|
|Jan 3, 2014||SEC - SEC FORM D|
|Jul 2, 2012||Bloomberg - MBA Startups Find Alumni Angels With Money to Burn|
|Jan 4, 2012||FinSMEs - FinSMEs|
|Jun 18, 2010||Med City News - CytoPherx raises $5M to develop dialysis filters|
Ann Arbor, MI